Fertility Services Market Size & Growth Forecast 2027–2036, By Segments (Provider, Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Fertility Services Market size was more than USD 52.7 billion in 2026 and is set to grow at a 7.13% CAGR between 2027 and 2036, attaining USD 104.94 billion by 2036. The industry revenue for 2027 is estimated at USD 55.86 billion.

• Base Year Value (2026): USD 52.7 billion
• CAGR (2027-2036): 7.13%
• Forecast Year Value (2036): USD 104.94 billion
• Historical Data Period: 2022-2026
• Largest Region: Europe
• Forecast Period: 2027-2036

Fertility Services Market Intelligence Snapshot:

• Regional Market Dynamics:

  • Europe held a 37.88% market share in 2026, supported by mature fertility clinic networks, broad ART availability, and strong clinical expertise that sustain high treatment volumes and consistent patient access.
  • Asia Pacific is projected to grow at an 8.59% CAGR, fueled by expanding fertility clinic capacity, broader treatment access, rising patient acceptance of assisted conception, and continued investment in modern reproductive care.

• Segment Momentum:

  • Fertility clinics accounted for 76.02% of the market in 2026 by offering specialized reproductive care, integrated diagnostics, treatment planning, and coordinated fertility procedures under one care pathway.
  • Preservation is the fastest-growing type segment as more individuals proactively seek fertility services before age-related decline, medical treatments, or delayed family planning.

• Market Expansion Drivers:

  • Rising global infertility rates driven by delayed pregnancies and lifestyle-related factors.
  • Increasing adoption of assisted reproductive technologies expanding access to fertility treatment.
  • Growth of specialized fertility clinics improving access and success rates of ART procedures.

• Leading Market Participants:

  Prominent companies in the fertility services market include Mayo Clinic (United States), Cleveland Clinic (United States), Monash IVF Group Limited (Australia), Virtus Health Limited (Australia), CARE Fertility Group (United Kingdom), Aspire Fertility (United States), Dallas IVF (United States), Apricity Fertility UK Limited (United Kingdom), King's Fertility Limited (United Kingdom), Prelude Fertility, Inc. (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 52.7 billion
  • 2027 Estimated Market Size: USD 55.86 billion.
  • Projected Market Size: USD 104.94 billion by 2036
  • Growth Forecasts: 7.13% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: Europe
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Fertility Clinics (Provider) | Treatment (Type)
  • Emerging Opportunity Segment: Fertility Clinics (Provider) | Preservation (Type)

Market Growth Drivers and Industry Trends

Rising global infertility rates driven by delayed pregnancies and lifestyle-related factors

Changing family-planning patterns and the increasing tendency to pursue parenthood at later reproductive ages are contributing to greater demand for fertility evaluation and treatment. The fertility services market is expanding as delayed pregnancies can increase the likelihood of reproductive challenges, while lifestyle-related factors and other environmental or health influences may further affect fertility outcomes. Individuals and couples are increasingly seeking consultations, diagnostic assessments, fertility preservation, and specialized treatment to better understand reproductive health, creating demand across both initial evaluation and more advanced fertility care pathways.

Increasing adoption of assisted reproductive technologies expanding access to fertility treatment

Greater awareness and acceptance of assisted reproductive technologies are enabling more individuals and couples to pursue medically supported conception options. The fertility services market is benefiting from wider use of procedures such as in vitro fertilization, intracytoplasmic sperm injection, embryo transfer, and related reproductive interventions that provide treatment options for different causes of infertility. Improvements in laboratory techniques, embryo assessment, cryopreservation, and treatment protocols are also supporting more individualized care, while growing familiarity with ART procedures is reducing barriers to seeking specialized fertility assistance.

Growth of specialized fertility clinics improving access and success rates of ART procedures

The development of specialized fertility centers is strengthening the availability of comprehensive reproductive care by bringing diagnostic, laboratory, procedural, and counseling services together within dedicated facilities. Expansion of these clinics is supporting the fertility services market by improving geographic access to assisted reproductive technologies and enabling patients to receive care from teams with focused expertise in reproductive medicine. Specialized infrastructure can also facilitate the adoption of advanced laboratory practices and standardized treatment protocols, while integrated patient management allows fertility specialists to tailor treatment pathways according to individual reproductive needs.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising global infertility rates driven by delayed pregnancies and lifestyle-related factors	2.00%	High	Europe, North America	High	Near Term
Increasing adoption of assisted reproductive technologies expanding access to fertility treatment	1.80%	High	Europe	High	Mid Term
Growth of specialized fertility clinics improving access and success rates of ART procedures	1.60%	Moderate	Europe, Asia Pacific	High	Mid Term

Regional Demand Dynamics

Europe (Largest Region) vs Asia Pacific (Fastest-Growing Region)

In the fertility services market, Europe held the largest share of 37.88% in 2026, underpinned by established reproductive healthcare systems, broad availability of assisted reproductive technologies, and growing acceptance of fertility treatment. The region benefits from specialized fertility clinics, experienced medical professionals, and regulatory frameworks that support the delivery and oversight of reproductive services. Delayed parenthood, changing family structures, and increasing awareness of fertility preservation are also contributing to demand. Continued advances in reproductive diagnostics, embryo-related procedures, and personalized treatment approaches are strengthening the region's position by expanding available options for individuals and couples seeking fertility care.

Asia Pacific represents the fastest-growing regional market as improving healthcare access, rising awareness of reproductive health, and increasing acceptance of assisted fertility procedures broaden the addressable patient base. Expanding private healthcare infrastructure and investment in specialized fertility centers are making advanced reproductive services more accessible across major urban areas. Demographic changes, delayed family formation, and growing recognition of age-related fertility challenges are further supporting demand. At the same time, increasing medical tourism and improvements in clinical expertise are encouraging patients to consider specialized fertility services, supporting stronger regional momentum.

Key Country Insights

United States

Advanced Reproductive Care

The U.S. fertility services market benefits from broad availability of assisted reproductive technologies and specialized fertility clinics. Providers in the U.S. continue expanding personalized treatment plans, genetic screening services, and digital patient engagement to improve clinical outcomes and patient experience.

Japan

Family Planning Support

Japan continues strengthening fertility services in response to changing demographic trends and delayed parenthood. Clinics across Japan increasingly focus on advanced reproductive technologies, fertility preservation, and patient-centered treatment pathways.

South Korea

Technology-Enabled Fertility Care

South Korea combines advanced reproductive medicine with modern clinical infrastructure to support fertility treatment demand. Healthcare providers in South Korea invest in laboratory innovation, embryo management technologies, and comprehensive reproductive counseling services.

Germany

Regulated Clinical Practice

Germany's fertility services market operates within a structured regulatory environment that emphasizes quality clinical care and patient safety. Fertility centers in Germany prioritize evidence-based treatments, laboratory excellence, and multidisciplinary reproductive health services.

France

Integrated Reproductive Services

France emphasizes coordinated fertility care through specialized reproductive health centers and established clinical protocols. Providers in France continue enhancing access to assisted reproductive procedures while maintaining strong standards for treatment quality and patient care.

Italy

Specialist Clinic Expansion

Italy continues expanding fertility services through specialized clinics offering comprehensive reproductive treatment options. Fertility providers in Italy focus on individualized patient management, laboratory capabilities, and improved access to advanced assisted reproduction techniques.

Segment Leadership and Growth Trends

 

Provider Segment Analysis: Fertility Clinics (Largest & Fastest-Growing Segment)

Fertility clinics dominated the fertility services market with a 76.02% share in 2026 and also represented the fastest-growing provider segment. These specialized facilities offer comprehensive fertility evaluation, assisted reproductive procedures, monitoring, and related clinical services within an integrated care environment. Their specialized expertise and access to dedicated reproductive technologies make fertility clinics a preferred setting for individuals seeking structured fertility treatment. Rising awareness of reproductive health, greater acceptance of assisted reproductive care, and improvements in fertility treatment capabilities are supporting continued demand for specialized clinic-based services.

Type Segment Analysis: Treatment (Largest Segment) vs Preservation (Fastest-Growing Segment)

Treatment services represented the largest segment of the fertility services market, accounting for a 63.37% share in 2026. Fertility treatment encompasses a broad range of clinical interventions designed to address infertility and support conception, making it central to reproductive healthcare. Growing awareness of available fertility options and increasing demand for specialized medical support are contributing to continued utilization of treatment services. Improvements in assisted reproductive technologies, personalized treatment approaches, and clinical monitoring are further strengthening the role of treatment services within fertility care.

Preservation is the fastest-growing type segment, driven by increasing awareness of fertility planning and the importance of preserving reproductive potential for future use. Fertility preservation services provide options for individuals who may wish to delay childbearing or protect reproductive potential before undergoing treatments or circumstances that could affect fertility. Greater awareness of reproductive planning and improvements in preservation techniques are broadening access to these services. The growing emphasis on personalized reproductive healthcare is further supporting demand for fertility preservation alongside conventional treatment services.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Provider	Fertility Clinics, Hospitals and Others	Fertility Clinics	Fertility Clinics
Type	Diagnosis, Treatment, Preservation	Treatment	Preservation

Competitive Landscape and Market Positioning

Prominent players in the fertility services market:

1. Mayo Clinic (United States)

2. Cleveland Clinic (United States)

3. Monash IVF Group Limited (Australia)

4. Virtus Health Limited (Australia)

5. CARE Fertility Group (United Kingdom)

6. Aspire Fertility (United States)

7. Dallas IVF (United States)

8. Apricity Fertility UK Limited (United Kingdom)

9. King's Fertility Limited (United Kingdom)

10. Prelude Fertility Inc. (United States)

The fertility services market is expanding due to increasing adoption of personalized reproductive treatment approaches. Innovation is centered on improving success rates through advanced genetic and embryology techniques. The fertility services market is also influenced by growing demand for integrated reproductive health solutions. Continuous advancement in laboratory technologies is improving treatment precision.

Industry Development/News

Company Name	Date	Key Development
Future Family	Sep-25	Future Family secured a $400 million financing program from Clear Haven Capital Management to scale its fertility lending platform. This capital enables broader patient access to IVF and egg-freezing financing, supporting the growth of its nationwide fertility insurance and patient financing ecosystem to meet increasing consumer demand for assisted reproductive services.
Ontario Government	Oct-25	The Ontario government launched a $250 million investment initiative to expand the Ontario Fertility Program. This funding aims to scale capacity across both hospital and community-based IVF providers, directly reducing wait times and improving equitable access to publicly funded reproductive healthcare services throughout the province.
NewGenIvf Group Limited	Aug-25	NewGenIvf Group Limited completed its SPAC merger with A SPAC I Acquisition and listed on the Nasdaq. The transaction provides the company with significant growth capital to accelerate the expansion of its fertility services platform across Asia and international markets, strengthening its competitive positioning in the global reproductive healthcare sector.
CHA Healthcare	Aug-25	CHA Healthcare acquired a controlling stake in Singapore Medical Group, integrating its multi-specialty network into a regional healthcare platform. This strategic consolidation expands CHA’s fertility and specialized medical service footprint across Southeast Asia, facilitating cross-border growth and enhancing service delivery capabilities in the region’s private healthcare market.
Indira IVF	Sep-25	Indira IVF acquired a stake in Banker IVF, strengthening its clinical presence in Gujarat. By combining its national operational scale with Banker IVF's regional network, the company aims to enhance IVF accessibility in key urban centers and optimize service delivery infrastructure across underserved Indian fertility markets.
FertGroup	Aug-25	FertGroup partnered with Future Fertility to implement AI-driven oocyte assessment software across its Brazilian clinic network. This integration of digital analytical tools enhances embryo and egg evaluation capabilities, supporting improved clinical decision-making and standardizing high-tech diagnostic outcomes across the provider’s regional facilities.
Blue Cross Blue Shield	Sep-25	Blue Cross Blue Shield Global Solutions partnered with Carrot to launch a global fertility and family-building benefits program for expatriate employees. This integration incorporates IVF and reproductive health services into international insurance offerings, marking a strategic expansion of employer-sponsored fertility benefits to support mobile workforces on a global scale.
HCA Healthcare UK	Oct-25	HCA Healthcare UK expanded its fertility services network by opening a dedicated satellite clinic at its Canary Wharf Outpatients Centre in London. The facility increases the provider's outpatient capacity, addressing high regional demand for assisted reproductive care through an integrated diagnostic and primary care service model.
Cryoport, Inc.	Apr-23	Cryoport, Inc. entered a three-year supply chain agreement with Boston IVF to standardize the logistics and transportation of sensitive reproductive materials across the U.S. This partnership addresses critical infrastructure needs in the fertility market, focusing on the secure, temperature-controlled transit of biological assets to maintain clinical viability during storage and transport.
Zora Health	Jul-25	Zora Health secured $1 million in seed funding to launch a digital fertility care platform. The investment is earmarked for building an integrated reproductive health coordination tool, which streamlines access to IVF, egg freezing, and fertility testing services through a tech-enabled interface designed to improve patient navigation and care efficiency.